Home

notizia edificio Leccare oxford immunotec spray pisolino Continentale

Case Study: Oxford Immunotec - Cezanne HR
Case Study: Oxford Immunotec - Cezanne HR

Oxford Immunotec Announces New Initiative to Bring the Benefit of Modern  Tuberculosis Testing to the Russian Federation - NAI 500
Oxford Immunotec Announces New Initiative to Bring the Benefit of Modern Tuberculosis Testing to the Russian Federation - NAI 500

Oxford Immunotec Office Photos
Oxford Immunotec Office Photos

ODL Service Closures - Oxford Diagnostic Laboratories
ODL Service Closures - Oxford Diagnostic Laboratories

Diagnostics technology pioneer Oxford Immunotec partners with IFS to drive  future growth - IFS
Diagnostics technology pioneer Oxford Immunotec partners with IFS to drive future growth - IFS

Global Headquarters & UK Oxford Diagnostic Laboratories - Oxford Immunotec  Careers
Global Headquarters & UK Oxford Diagnostic Laboratories - Oxford Immunotec Careers

Expert Series with Dr. Ali Hassoun – Oxford Immunotec Medical Education
Expert Series with Dr. Ali Hassoun – Oxford Immunotec Medical Education

PerkinElmer acquires Oxford Immunotec to expand its TB test portfolio
PerkinElmer acquires Oxford Immunotec to expand its TB test portfolio

Oxford Immunotec - Satedia Srl Distributore Ufficiale Sicilia
Oxford Immunotec - Satedia Srl Distributore Ufficiale Sicilia

Oxford Immunotec Ltd - Product Pipeline Analysis, 2021 Update
Oxford Immunotec Ltd - Product Pipeline Analysis, 2021 Update

Commercial - Oxford Immunotec Careers
Commercial - Oxford Immunotec Careers

Oxford Immunotec - Kaiser Permanente Ventures
Oxford Immunotec - Kaiser Permanente Ventures

Oxford Immunotec Announces Agreement with Stop TB Partnership – Global Drug  Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden  Countries - T-SPOT.TB Test for Korea
Oxford Immunotec Announces Agreement with Stop TB Partnership – Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries - T-SPOT.TB Test for Korea

PerkinElmer completes Oxford Immunotec acquisition - MassDevice
PerkinElmer completes Oxford Immunotec acquisition - MassDevice

Locations - Oxford Immunotec Careers
Locations - Oxford Immunotec Careers

Oxford Immunotec's T-Cell Reagent Kit FDA Approved to Automate TB Detection  Solution | Clinical Lab Products
Oxford Immunotec's T-Cell Reagent Kit FDA Approved to Automate TB Detection Solution | Clinical Lab Products

T-SPOT Discovery (Research Use Only) | T cell response to SARS-CoV-2
T-SPOT Discovery (Research Use Only) | T cell response to SARS-CoV-2

Oxford Immunotec - Wellington
Oxford Immunotec - Wellington

Kit di reagenti anticorpo - T-Cell Xtend® - Oxford Immunotec Ltd. - da  laboratorio / di campioni di sangue
Kit di reagenti anticorpo - T-Cell Xtend® - Oxford Immunotec Ltd. - da laboratorio / di campioni di sangue

Oxford Immunotec to supply T cell testing for UK COVID-19 vaccine trials
Oxford Immunotec to supply T cell testing for UK COVID-19 vaccine trials

PerkinElmer to acquire Oxford Immunotec - The Oxford Magazine
PerkinElmer to acquire Oxford Immunotec - The Oxford Magazine

Oxford Immunotec - Crunchbase Company Profile & Funding
Oxford Immunotec - Crunchbase Company Profile & Funding

PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC

Contattaci
Contattaci

Oxford Immunotec Company Profile: Valuation, Investors, Acquisition |  PitchBook
Oxford Immunotec Company Profile: Valuation, Investors, Acquisition | PitchBook

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and  CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T  cell) Immune Response to SARS-CoV-2 Infection
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection